Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: J Mol Cell Cardiol. 2017 Jan 21;104:63–74. doi: 10.1016/j.yjmcc.2017.01.009

Fig. 8.

Fig. 8

FGF13 cardiac-specific knockout mice showed abnormal ECG phenotype and drug inducible ventricular tachyarrhythmias. Example ECG traces from Myh6-MCM (Cre) (A) and Fgf13 KO (KO) (B) mice un-induced, tamoxifen induced without flecainide challenge, or tamoxifen-induced with flecainide challenge. (C) Ventricular tachycardia was observed after flecainide challenge only in tamoxifen induced Fgf13 KO mice. Summarized data for P wave(D), PQ interval(E), and QRS interval(F) in WT, Cre, and Fgf13 KO mice. *indicates p<0.05, **indicates p<0.01 versus un-induced, #indicates p<0.05, ##indicates p<0.01 versus Tamoxifen, †indicates p<0.05, versus WT at the respective condition. The numbers of mice used are indicated within each bar plot.